| 000 | 00967 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250511225243.0 | ||
| 264 | 0 | _c19900420 | |
| 008 | 199004s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/bjc.1990.35 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNewell, D R | |
| 245 | 0 | 0 |
_aPhase I clinical studies with cytotoxic drugs: pharmacokinetic and pharmacodynamic considerations. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cFeb 1990 |
||
| 300 |
_a189-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMethods |
| 650 | 0 | 4 | _aMice |
| 773 | 0 |
_tBritish journal of cancer _gvol. 61 _gno. 2 _gp. 189-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.1990.35 _zAvailable from publisher's website |
| 999 |
_c2184791 _d2184791 |
||